These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22022577)

  • 21. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.
    Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH
    J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics.
    Mendoza-Parra MA; Walia M; Sankar M; Gronemeyer H
    Mol Syst Biol; 2011 Oct; 7():538. PubMed ID: 21988834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
    Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
    Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ERAP140/Nbla10993 is a novel favorable prognostic indicator for neuroblastoma induced in response to retinoic acid.
    Arai H; Ozaki T; Niizuma H; Nakamura Y; Ohira M; Takano K; Matsumoto M; Nakagawara A
    Oncol Rep; 2008 Jun; 19(6):1381-8. PubMed ID: 18497940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
    Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
    Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells.
    Kotapalli SS; Dasari C; Duscharla D; Kami Reddy KR; Kasula M; Ummanni R
    J Cell Biochem; 2017 Dec; 118(12):4358-4369. PubMed ID: 28436114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells.
    Tanaka T; Rodríguez de la Concepción ML; De Luca LM
    Biochem Pharmacol; 2001 Jun; 61(11):1347-55. PubMed ID: 11331070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
    Akter J; Takatori A; Hossain MS; Ozaki T; Nakazawa A; Ohira M; Suenaga Y; Nakagawara A
    Clin Cancer Res; 2011 Nov; 17(21):6681-92. PubMed ID: 21908575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma.
    Woo CW; Tan F; Cassano H; Lee J; Lee KC; Thiele CJ
    Pediatr Blood Cancer; 2008 Feb; 50(2):208-12. PubMed ID: 17420990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoic acid activates monoamine oxidase B promoter in human neuronal cells.
    Wu JB; Chen K; Ou XM; Shih JC
    J Biol Chem; 2009 Jun; 284(25):16723-16735. PubMed ID: 19401466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells.
    Wu Q; Lin XF; Ye XF; Zhang B; Xie Z; Su WJ
    J Mol Endocrinol; 2004 Jun; 32(3):595-613. PubMed ID: 15171703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement of retinoic acid receptor isotypes alpha, beta, and gamma during the initial steps of neural differentiation of PCC7 cells.
    Zechel C
    Mol Endocrinol; 2005 Jun; 19(6):1629-45. PubMed ID: 15831518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid up-regulates nuclear retinoic acid receptor-alpha expression in human neuroblastoma cells.
    Wuarin L; Chang B; Wada R; Sidell N
    Int J Cancer; 1994 Mar; 56(6):840-5. PubMed ID: 8119774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of 9-cis, 13-cis and all-trans retinoic acids on the neuronal differentiation of human neuroblastoma cells.
    Chu PW; Cheung WM; Kwong YL
    Neuroreport; 2003 Oct; 14(15):1935-9. PubMed ID: 14561924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex.
    Delva L; Bastie JN; Rochette-Egly C; Kraïba R; Balitrand N; Despouy G; Chambon P; Chomienne C
    Mol Cell Biol; 1999 Oct; 19(10):7158-67. PubMed ID: 10490651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S; Tweardy DJ
    Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis.
    Hatoum A; El-Sabban ME; Khoury J; Yuspa SH; Darwiche N
    Carcinogenesis; 2001 Dec; 22(12):1955-63. PubMed ID: 11751425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.
    Chen Q; Ross AC
    Exp Cell Res; 2004 Jul; 297(1):68-81. PubMed ID: 15194426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.
    Huang S; Laoukili J; Epping MT; Koster J; Hölzel M; Westerman BA; Nijkamp W; Hata A; Asgharzadeh S; Seeger RC; Versteeg R; Beijersbergen RL; Bernards R
    Cancer Cell; 2009 Apr; 15(4):328-40. PubMed ID: 19345331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.